My research interests are mainly focused in the design and development of new organic, inorganic and organometallic drugs put in perspective for applications in healthcare. Currently I am involved in the design and synthesis of new ruthenium(II/III),) iron(II) and copper(I) complexes containing targeting molecules (e.g. peptides, carbohydrates, biomolecules) in their structure for the selective inhibition of the growth of cancer cells and metastases. Also, I am interested in the evaluation of the studied compounds as potential drugs and interaction studies with biomolecules (DNA, serum proteins, enzymes).